Metabolic Reprogramming at the Edge of Redox: Connections Between Metabolic Reprogramming and Cancer Redox State

被引:0
|
作者
Serrano, Jose J. [1 ]
Medina, Miguel angel [1 ,2 ,3 ]
机构
[1] Univ Malaga, Fac Ciencias, Dept Biol Mol & Bioquim, E-29071 Malaga, Spain
[2] BIONAND Biomed Res Inst Malaga, Inst Invest Biomed & Plataforma Nanomed IBIMA Plat, E-29071 Malaga, Spain
[3] Spanish Network Res Ctr Rare Dis, Inst Salud Carlos 3, CIBER Enfermedades Raras, CIBERER, E-28029 Madrid, Spain
关键词
redox; cancer; metabolism; feedback; emergence; reprogramming; PENTOSE-PHOSPHATE PATHWAY; ONE-CARBON METABOLISM; GLUTAMINE-METABOLISM; OXIDATIVE STRESS; SERINE METABOLISM; NRF2; TRANSCRIPTION; SUPPORTS; PROLINE; HOMEOSTASIS;
D O I
10.3390/ijms26020498
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The importance of redox systems as fundamental elements in biology is now widely recognized across diverse fields, from ecology to cellular biology. Their connection to metabolism is particularly significant, as it plays a critical role in energy regulation and distribution within organisms. Over recent decades, metabolism has emerged as a relevant focus in studies of biological regulation, especially following its recognition as a hallmark of cancer. This shift has broadened cancer research beyond strictly genetic perspectives. The interaction between metabolism and redox systems in carcinogenesis involves the regulation of essential metabolic pathways, such as glycolysis and the Krebs cycle, as well as the involvement of redox-active components like specific amino acids and cofactors. The feedback mechanisms linking redox systems and metabolism in cancer highlight the development of redox patterns that enhance the flexibility and adaptability of tumor processes, influencing larger-scale biological phenomena such as circadian rhythms and epigenetics.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Reprogramming the cancer epigenome by "metabolic transduction"
    Byun, Jung S.
    Gardner, Kevin
    FASEB JOURNAL, 2012, 26
  • [32] The cancer metabolic reprogramming and immune response
    Xia, Longzheng
    Oyang, Linda
    Lin, Jinguan
    Tan, Shiming
    Han, Yaqian
    Wu, Nayiyuan
    Yi, Pin
    Tang, Lu
    Pan, Qing
    Rao, Shan
    Liang, Jiaxin
    Tang, Yanyan
    Su, Min
    Luo, Xia
    Yang, Yiqing
    Shi, Yingrui
    Wang, Hui
    Zhou, Yujuan
    Liao, Qianjin
    MOLECULAR CANCER, 2021, 20 (01)
  • [33] Intracellular Transport in Cancer Metabolic Reprogramming
    Sneeggen, Marte
    Guadagno, Noemi Antonella
    Progida, Cinzia
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [34] Metabolic reprogramming in epithelial ovarian cancer
    Nantasupha, Chalaithorn
    Thonusin, Chanisa
    Charoenkwan, Kittipat
    Chattipakorn, Siriporn
    Chattipakorn, Nipon
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (09): : 9950 - 9973
  • [35] Oxygen availability and metabolic reprogramming in cancer
    Xie, Hong
    Simon, M. Celeste
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (41) : 16825 - 16832
  • [36] Metabolic reprogramming and cancer progression in patients
    DeBerardinis, Ralph J.
    CANCER RESEARCH, 2024, 84 (05)
  • [37] The cancer metabolic reprogramming and immune response
    Longzheng Xia
    Linda Oyang
    Jinguan Lin
    Shiming Tan
    Yaqian Han
    Nayiyuan Wu
    Pin Yi
    Lu Tang
    Qing Pan
    Shan Rao
    Jiaxin Liang
    Yanyan Tang
    Min Su
    Xia Luo
    Yiqing Yang
    Yingrui Shi
    Hui Wang
    Yujuan Zhou
    Qianjin Liao
    Molecular Cancer, 20
  • [38] Metabolic reprogramming in cancer: Mechanisms and therapeutics
    Nong, Shiqi
    Han, Xiaoyue
    Xiang, Yu
    Qian, Yuran
    Wei, Yuhao
    Zhang, Tingyue
    Tian, Keyue
    Shen, Kai
    Yang, Jing
    Ma, Xuelei
    MEDCOMM, 2023, 4 (02):
  • [39] Editorial: Metabolic reprogramming in breast cancer
    Scatena, Cristian
    Naccarato, Antonio Giuseppe
    Ozsvari, Bela
    Scumaci, Domenica
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] Metabolomics and Metabolic Reprogramming in Kidney Cancer
    Weiss, Robert H.
    SEMINARS IN NEPHROLOGY, 2018, 38 (02) : 175 - 182